ARCHIVES

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 7, 2000

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

Boston Meeting To Look At “IRBs At Crsswoad”

August 12, 1988

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

New Jersey Legislature Votes to Oppose USPSTF PSA Screening Downgrade

January 20, 2012